Therapeutic effects of lornoxicam-loaded nanomicellar formula in experimental models of rheumatoid arthritis
Hebatullah Samy Helmy,1 Ayman E El-Sahar,2 Rabab H Sayed,2 Rehab Nabil Shamma,3 Alaa Hamed Salama,4 Eman Maher Elbaz1 1Department of Biochemistry, 2Department of Pharmacology and Toxicology, 3Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, 4Department of...
Guardado en:
Autores principales: | Helmy HS, El-Sahar AE, Sayed RH, Shamma RN, Salama AH, Elbaz EM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/99d373e34d02436ab33a346885edc585 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Enhanced transdermal delivery of lornoxicam by nanostructured lipid carrier gels modified with polyarginine peptide for treatment of carrageenan-induced rat paw edema
por: Gao S, et al.
Publicado: (2019) -
Acupuncture versus Lornoxicam in the Treatment of Acute Renal Colic: A Randomized Controlled Trial
por: Zhang X, et al.
Publicado: (2021) -
AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers
por: Xin J, et al.
Publicado: (2018) -
Potential Privilege of Maltodextrin-α-Tocopherol Nano-Micelles in Seizing Tacrolimus Renal Toxicity, Managing Rheumatoid Arthritis and Accelerating Bone Regeneration
por: Helal HM, et al.
Publicado: (2021) -
Bilosomes as Promising Nanovesicular Carriers for Improved Transdermal Delivery: Construction, in vitro Optimization, ex vivo Permeation and in vivo Evaluation
por: Ahmed S, et al.
Publicado: (2020)